Capricor Therapeutics, Inc. (CAPR) vs Eikon Therapeutics, Inc. Common Stock (EIKN)

A side-by-side comparison of Capricor Therapeutics, Inc. and Eikon Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Capricor Therapeutics, Inc. logo
CAPR
Capricor Therapeutics, Inc.
$438M
$7.62HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Eikon Therapeutics, Inc. Common Stock logo
EIKN
Eikon Therapeutics, Inc. Common Stock
$415M
$7.66HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT

Total return — CAPR vs EIKN

growth of $100 · dividends reinvested · last 1y
CAPR -66.2% (-66.2%/yr)EIKN -49.7% (-49.7%/yr)EIKN compounded faster over this window
50100150Start $100$34$50
CAPR EIKN

CAPR vs EIKN: by the numbers

  • •CAPR is the larger company ($438M vs $415M market cap).

Metrics side by side

Valuation

MetricCAPREIKN
P/B ratio1.780.89
EV / EBITDA0.44N/A

Profitability

MetricCAPREIKN
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-52.56%-69.06%
ROIC-40.25%-46.16%

Growth (annualized)

MetricCAPREIKN
Total return CAGR (5Y)15.17%N/A

Go deeper

Full CAPR analysisFull EIKN analysisInteractive comparison tool

Dig into the metrics

Capricor Therapeutics ROEEikon Therapeutics, Inc. Common Stock ROECapricor Therapeutics operating marginEikon Therapeutics, Inc. Common Stock operating marginCapricor Therapeutics revenue growthEikon Therapeutics, Inc. Common Stock revenue growthCapricor Therapeutics free cash flowEikon Therapeutics, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.